: ,

Antonarakis SE: The molecular genetics of hemophilia A and in man. Factor III and factor IX deficiency. Adv Hum Genet 17:17, 1988

Destefano V et al: Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 87:3531, 1996

Feinstein DI: Lupus anticoagulant, anticardiolipin antibodies, fetal loss and systemic lupus eiythematosus. Blood 80:859, 1992

Giddings JC, Peake IR: Laboratory support in the diagnosis of coagulation disorders. ClinHaematol 14:571, 1985

Ginsburg KJ et al: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997, 1992

Kane WH, Davie EW: Blood coagulation factors Vand VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539, 1988

Kasper CK, Dietrich SL: Comprehensive management of haemophilia. Clin Haematol 14:489, 1985

Lakich D et al: Inversions disrupting the factor VIII gene are a common cause of servere hemophilia A. Nat Genet 5:226, 1993

Lawn R: The molecular genetics of hemophilia. Sci Am 254:48, 1986

Lusher JM et al: Recombinant factor VIII for the treatment of untreated patients with hemophilia A: Safety, efficacy and development of inhibitors. N Engl J Med 328:453, 1993

Mammen E: Congenital coagulation disorders. Semin Thromb Hemost 9:l, 1983

Pierce GF et al: The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost and supply on therapy. JAMA 261:3434, 1989

White GC, Shoemaker CB: Factor VIII gene and hemophilia A. Blood 73:1, 1989


  • :